New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 7, 2014
09:10 EDTWWE, MNKD, P, QCOR, AGIO, AEO, VOCS, PFE, MAT, MNKOn The Fly: Pre-market Movers
HIGHER: Questcor (QCOR), up 27% after agreeing to be bought by Mallinckrodt (MNK) for cash, stock valued at $86.10 per Questcor share... Agios Pharmaceuticals (AGIO), up 25% after program shows "promising clinical activity" for advanced blood cancers, shares upgraded at JPMorgan... Vocus (VOCS), up 47% after agreeing to be acquired by GTCR for $446.5M, or $18.00 per share... Pandora (P), up 1.3% following upgrade at Wedbush. LOWER: MannKind (MNKD), down 13% after announcing FDA extension of PDUFA date for Afrezza... American Eagle (AEO), down 2.2% following downgrade at Cowen... Pfizer (PFE), down 2.8% after announcing data for palbociclib in metastatic breast cancer... Mattel (MAT), down 3% following downgrade at BMO Capital... WWE (WWE), down 1.2% after cautious mention in Barron's, company announcing WrestleMania 30 grossed $10.9M.
News For QCOR;MNK;VOCS;P;MAT;AEO;MNKD;PFE;AGIO;WWE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
April 16, 2015
18:56 EDTMATMattel announces partnership with Quirky
Subscribe for More Information
16:12 EDTMATMattel trades up after results, levels to watch
Subscribe for More Information
16:06 EDTMATMattel reports Q1 adjusted EPS (8c), consensus (9c)
Reports Q1 revenue $922.7M, consensus $896.54M.
15:23 EDTMATNotable companies reporting after market close
Subscribe for More Information
13:22 EDTWWEWWE says WWE Network currently reaches over 1.3M subscribers
Subscribe for More Information
11:43 EDTMATMattel management to meet with MKM Partners
Subscribe for More Information
10:00 EDTMATOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:51 EDTMATMattel upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo upgraded Mattel to Outperform citing a favorable risk/reward following the recent underperformance of shares. Wells views the stock as an attractive value play, with downside protection given the potential for a leveraged buyout. It has a $28-$30 price target range for shares.
April 15, 2015
11:25 EDTMNKMallinckrodt management to meet with Jefferies
Meetings to be held in Boston/New York on April 21-22 hosted by Jefferies.
10:00 EDTAEOOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:51 EDTMATMattel April volatility elevated into Q1 and outlook
Subscribe for More Information
08:04 EDTPFEPfizer: PALOMA-3 trial for IBRANCE met primary endpoint, trial stopped early
Subscribe for More Information
07:41 EDTMNKEBD Group to hold a forum
ChinaBio Partnering Forum 2015 is being held in Shanghai, China on April 15-16.
06:56 EDTAEOAmerican Eagle initiated with a Buy at Guggenheim
Target $20.
05:51 EDTMNKDStocks with implied volatility movement; ZIOP MNKD
Subscribe for More Information
April 13, 2015
17:32 EDTMNKMallinckrodt says Questcor to pay $38M in proposed settlement
Subscribe for More Information
15:12 EDTPFEMylan enters settlement, license agreement with Pfizer regarding Viagra
Mylan (MYL) announced that its subsidiaries Mylan Inc. and Mylan Pharmaceuticals have entered into a settlement and license agreement with Pfizer (PFE), Pfizer Limited and Pfizer Ireland Pharmaceuticals to settle patent litigation relating to Mylan's Abbreviated New Drug Application filed with the U.S. FDA for Sildenafil Citrate Tablets 25 mg, 50 mg, and 100 mg. This product is the generic version of Viagra, which is indicated to treat erectile dysfunction. Under the terms of the agreement, Mylan will be able to launch its ANDA products pursuant to a royalty-bearing license as early as December 11, 2017, or sooner under certain conditions, subject to FDA approval. All other terms and conditions of the settlement and license agreement are confidential, and the agreement itself is subject to review by the U.S. Department of Justice and the Federal Trade Commission. For the 12 months ending Dec. 31, 2014, Viagra had U.S. sales of approximately $1.3B, according to IMS Health.
09:16 EDTPPandora gaps up, levels to watch
Subscribe for More Information
08:42 EDTPPandora rises after Spotify reportedly valued above $8B in fundraising
Subscribe for More Information
07:16 EDTPTechWeek to hold a conference
TechWeek Detroit 2015 is being held in Detroit on 4/13-19.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use